These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5333412)

  • 21. [Treatment of diabetic retinopathy with adrenal cortex hormones and anabolic agents].
    Merlin U
    G Veneto Sci Med; 1965; 20(3):129-37. PubMed ID: 5839485
    [No Abstract]   [Full Text] [Related]  

  • 22. The phytogenic anabolic steroid in the management of fracture cases. An experimental and clinical study.
    Gode JD; Prasad G; Sen SP; Udupa KN
    J Indian Med Assoc; 1966 May; 46(9):475-80. PubMed ID: 5330789
    [No Abstract]   [Full Text] [Related]  

  • 23. Prospects for angiotensin receptor blockers in diabetic retinopathy.
    Sjølie AK
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controlled clinical trials of the use of a new anabolic agent in a Sanatorium].
    Porsio A; Borgia M
    Clin Ter; 1966 Jun; 37(6):502-18. PubMed ID: 4865920
    [No Abstract]   [Full Text] [Related]  

  • 25. [Present-day management of the general treatment of diabetic retinopathy].
    Popa DP; Canciu G
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1978; 27(2):119-21. PubMed ID: 566942
    [No Abstract]   [Full Text] [Related]  

  • 26. [Some aspects of pathogenetic therapy of diabetic angiopathies].
    Efimov AS; Skrobonskaia NA; Karabun PM; Danilova AI; Zubkova ST; Naumenko VG; Mankovskiĭ BN; Melńik IM; Malik A; Tkachuk IuV
    Klin Med (Mosk); 1994; 72(1):20-3. PubMed ID: 8196316
    [No Abstract]   [Full Text] [Related]  

  • 27. [New prospects in the treatment of diabetic retinopathy. Current situation and pharmacological developments].
    Lagrèze WA
    MMW Fortschr Med; 2003 Apr; 145(14):37-8. PubMed ID: 15072277
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of osteoporosis with an enolic ether of dihydrotestosterone. (Clinical studies)].
    Domeniconi S
    Chir Organi Mov; 1966; 54(5):409-14. PubMed ID: 5333788
    [No Abstract]   [Full Text] [Related]  

  • 29. [Calcium dobesilate in the combination therapy of diabetic retinopathy].
    Margolis MG; Zheleznova VF
    Vestn Oftalmol; 1981; (2):46-7. PubMed ID: 7233686
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical efficacy of eiconol in patients with diabetic retinopathy].
    Sorokin EL; Smoliakova GP; Bachaldin IL
    Vestn Oftalmol; 1997; 113(4):37-9. PubMed ID: 9381643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined treatment of diabetic retinopathy and angiopathy with stilbestrol and testosterone].
    Szpilewski S; Lodygowska K
    Klin Oczna; 1974 Sep; 44(9):895-9. PubMed ID: 4408963
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current status of the treatment of diabetic retinopathy].
    Pérez-Salvador JL; Menezo JL
    Rev Clin Esp; 1971 Dec; 123(6):573-6. PubMed ID: 4946358
    [No Abstract]   [Full Text] [Related]  

  • 33. [The treatment of retinal circulatory disorders in practice. A contribution to the cooperation between the internist and the ophthalmologist].
    Zielinski HW
    Munch Med Wochenschr; 1965 Dec; 107(50):2560-4. PubMed ID: 5331159
    [No Abstract]   [Full Text] [Related]  

  • 34. The diabetic retinopathy study and the early treatment diabetic retinopathy study.
    Cantrill HL
    Int Ophthalmol Clin; 1984; 24(4):13-29. PubMed ID: 6389409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Course of diabetic retinopathy in patients treated with insulin and with new antidiabetic drugs].
    Ronchieri M
    Atti Accad Fisiocrit Siena Med Fis; 1964; 13(1):507-12. PubMed ID: 5839983
    [No Abstract]   [Full Text] [Related]  

  • 36. [Various internal medicine aspects of the future therapy for diabetic retinopathy].
    Houtsmuller AJ
    Klin Monbl Augenheilkd; 1972 May; 160(5):521-7. PubMed ID: 5075948
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of diabetic retinopathy. First results obtained with 2 recent products: daflon (Servier lab.) and diabtyl (Stago lab)].
    Boudet ; Garbal
    Bull Soc Ophtalmol Fr; 1972; 72(7):765-76. PubMed ID: 4661348
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical findings on the therapeutic action of a long-acting anabolic agent.
    Luppino V
    Panminerva Med; 1965 Oct; 7(10):392-8. PubMed ID: 5320934
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diabetic retinopathy with continuous subcutaneous insulin infusion therapy (insulin pump)].
    Bernsmeier H; Sonnenberg GE
    Fortschr Ophthalmol; 1984; 81(3):267-70. PubMed ID: 6479784
    [No Abstract]   [Full Text] [Related]  

  • 40. Mortality experience in the diabetic retinopathy study.
    Knatterud GL
    Isr J Med Sci; 1983 May; 19(5):424-8. PubMed ID: 6345462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.